手术治疗假体周围关节感染中抗生素耐药菌的十年趋势:区域转诊中心经验
该研究回顾性分析2010年至2021年915例符合Musculoskeletal Infection Society标准的手术治疗假体周围关节感染(PJI),耐药菌PJI占比从2010年41.5%(22/53)降至2021年25.1%(30/109)(P=0.85)。高合并症负担(P=0.04)和局部肢体受损(P=0.01)与耐药感染显著相关。
要点
- 耐药菌PJI占比从2010年41.5%(22/53)降至2021年25.1%(30/109),无显著趋势(P=0.85)。
- 高合并症负担(P=0.04)和局部肢体受损(P=0.01)与耐药感染显著相关。
- 耐药菌以耐甲氧西林金黄色葡萄球菌(63.0%)、耐甲氧西林表皮葡萄球菌(24.3%)和耐药凝固酶阴性葡萄球菌(16.1%)最常见。
核心结论
- 转诊至本中心的PJI病例随时间增加,但手术治疗PJI中耐药菌所致比例下降,尽管不显著。
- 高合并症负担和局部肢体受损可预测耐药感染。
研究设计与样本
- 回顾性审查本机构数据库,纳入2010年1月1日至2021年12月31日手术治疗且符合Musculoskeletal Infection Society标准的PJI患者,共915例。
主要发现
- 总PJI病例从2010年53例增至2021年109例,耐药菌病例从22例增至30例。
- 耐药PJI百分比从2010年41.5%(22/53)降至2021年25.1%(30/109),无显著趋势(P=0.85)。
- 915例手术中25.1%(N=230)由耐药菌引起。
- 高合并症负担患者耐药感染率显著更高(P=0.04),局部肢体受损患者同样显著更高(P=0.01)。
- 耐甲氧西林表皮葡萄球菌和耐药凝固酶阴性葡萄球菌在膝关节感染中更常见。
关键数值与推荐
- 耐药菌中最常见为耐甲氧西林金黄色葡萄球菌(63.0%)、耐甲氧西林表皮葡萄球菌(24.3%)和耐药凝固酶阴性葡萄球菌(16.1%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic joint infection (PJI) represents a devastating complication following total joint arthroplasty. Understanding trends in causative organisms and antibiotic resistance patterns is necessary for optimizing treatment strategies. We investigated (1) whether there has been a change in prevalence of drug-resistant organisms in surgically treated PJI over the past decade and (2) if there are risk factors associated with drug-resistant PJI. METHODS: A retrospective review of our institutional database was performed for surgically treated PJI between January 1, 2010, and December 31, 2021. A total of 915 patients met Musculoskeletal Infection Society criteria for PJI. The prevalence of patients who had drug-resistant organisms was recorded and compared over the study duration. Of 915 procedures, 25.1% (N = 230) were caused by resistant organisms. The most common resistant organisms were methicillin-resistant Staphylococcus aureus (63.0%), methicillin-resistant Staphylococcus epidermidis (24.3%), and resistant coagulase-negative Staphylococci (16.1%). RESULTS: Total PJI cases increased from 53 in 2010 to 109 in 2021, while resistant organism cases increased from 22 to 30. The percentage of resistant PJI decreased from 41.5% (22 of 53) in 2010 to 25.1% (30 of 109) in 2021, with no significant trend (P = 0.85). Patients who had higher comorbidity burden had significantly higher rates of resistant infections (P = 0.04), as did patients who had local extremity compromise (P = 0.01). The methicillin-resistant Staphylococcus epidermidis and resistant coagulase-negative Staphylococci were more common in knee infections. CONCLUSIONS: While PJI referrals to our center increased over time, the percentage of surgically treated PJIs caused by resistant organisms decreased, although not significantly. Patients who had a higher comorbidity burden and local extremity compromise were predictive of resistant infections. Understanding microbiological profiles remains critical for optimizing treatment strategies in referral centers.
引用
- Chandler CC, Graham SD, Hietpas KT, et al. Trends in Antibiotic-Resistant Bacteria in Surgically Treated Periprosthetic Joint Infection: A Decade of Experience at a Regional Referral Center. J Arthroplasty. 2025. PMID: 41205721. doi:10.1016/j.arth.2025.10.119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。